James Cameron



Based in Berlin, James specialises in science and technology. He has worked with the UK’s Parliamentary Office of Science and Technology to produce research on Advanced Therapy Medicinal Product (ATMP) regulation, and is a primary contributor to the firm’s Technologies Series.

Prior to joining the Llewellyn team, James undertook his PhD at the University of Birmingham and is presently a Research Fellow at the Deutsches Rheuma-Forschungszentrum (DRFZ) in Berlin. James holds a first-class honours degree in Biochemistry from the University of York, and PhD from the University of Birmingham.